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ABSTRACT
Morelloflavone, a biflavonoid from Southeast Asian folk medical plant Garcinia dulcis, possesses powerful antioxidant 
activity both in vivo and in vitro. We aimed to evaluate the hypotensive and diuretic effect of morelloflavone in two-kidneys-
one-clip (2K1C) renovascular hypertensive rats together with its vasorelaxant mechanism. Male Wistar rats (175±4 g) 
were undergone 2K1C and sham operation (SO) (n=6, each group). Four weeks  after the rats were anesthetized and 
clearance markers (0.5% para-aminohippuric acid and 1% inulin) were given via a jugular vein (1.6 mL/h/100 g BW) 
to estimate renal blood flow (RBF) and glomerular filtration rate.  The arterial blood pressure (AP) was monitored via a 
carotid artery and urine samples were collected. After equilibration, either morelloflavone or vehicle (DMSO) was given 
(0.1 mg/kg BW+5 μg/min/kg BW). Baroreflex sensitivity (BRS) (ΔHR/ΔMAP) was performed by an intravenous injection 
of 1, 2, 4, 8, 16 and 32 μg/kg BW phenylephrine (PE) or sodium nitroprusside. The PE-preconstricted isolated thoracic 
aortic rings (intact and denuded) relaxation were experimented using organ bath technique by cumulative additions of 
morelloflavaone (10-13-10-5 M) in the presence of specific vasorelaxant inhibitors and expressed as %relaxation from pre-
contraction tension. In 2K1C rats, morelloflavone significantly lowered mean AP, increased RBF and increased urine flow 
rate when compared to vehicle control (138±6 vs. 152±1 mmHg, 3.44±0.49 vs. 2.29±0.25 mL/min/g KW and 42.0±9.4 vs. 
18.2±3.9 μL/min/g KW, p<0.05), respectively and also restored the blunt BRS. Nitric oxide signaling pathway triggered 
by morelloflavone might be responsible for its diuretic and hypotensive effect.
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ABSTRAK
Moreloflavon, biflavonoid tumbuhan perubatan tempatan Garcinia dulcis dari Asia Tenggara mempunyai aktiviti 
antioksidan yang kuat secara in vivo dan in vitro. Tujuan penyelidikan ini ialah untuk menilai kesan hipotensif dan 
diuretik moreloflavon renovascular tikus hipertensi dua buah pinggang satu klip (2K1C) bersama-sama dengan 
mekanisme vasorelaksan. Tikus jantan Wistar (175±4 g) telah menjalani pembedahan 2K1C dan sham (SO) (n=6, setiap 
kumpulan). Empat minggu selepas itu, tikus telah dianestetik dan penanda pelepasan (0.5% asid para-aminohipurik 
dan 1% inulin) diberikan melalui urat jugulum (1.6 mL/jam/100 g BW) untuk menganggar aliran darah ginjal (RBF) dan 
kadar penurasan glomerulus. Tekanan darah arteri (AP) dipantau melalui arteri karotid dan sampel air kencing diambil. 
Selepas penyeimbangan, moreloflavon atau wahana (DMSO) telah diberikan (0.1 mg/kg BW+5 μg/min/kg BW). Sensitiviti 
barorefleks (BRS) (ΔHR/ΔMAP) telah dijalankan melalui suntikan intravena 1, 2, 4, 8, 16 dan 32 μg/kg BW fenilefrina 
(PE) atau sodium nitroprusida. PE-praberkuncup yang dipencilkan oleh pengenduran gegelang aorta toraks (utuh dan 
tersulah) telah dieksperimentasi menggunakan teknik mandian organ dengan penambahan kumulatif moreloflavon 
(10-13-10-5M) dengan kehadiran perencatan vasorelaksan tertentu dan dinyatakan sebagai %pengenduran daripada 
ketegangan pra-pengecutan. Pada tikus 2K1C, moreloflavon dengan ketara menurunkan min AP, meningkatkan RBF 
serta meningkatkan kadar aliran air kencing berbanding wahana kawalan masing-masing (138±6 vs 152±1 mmHg, 
3.44±0.49 vs 2.29±0.25 mL/min/g KW dan 42.0±9.4 vs 18.2±3.9 μL/min/g KW, p<0.05) dan juga memulihkan BRS yang 
tumpul. Oksida nitrik yang memberi isyarat laluan dicetuskan oleh moreloflavon mungkin bertanggungjawab terhadap 
kesan diuretik dan hipotensif. 
Kata kunci: Diuretik; dua buah pinggang satu-klip; Garcinia dulcis; hipotensif; moreloflavon
INTRODUCTION
Garcinia dulcis Kurz, a plant that belongs to the Guttiferae 
family, is widely distributed in Thailand and other 
Southeast Asian countries. G. dulcis is known as ‘maphuut’ 
in Thailand and as ‘mundu’ in Malaysia and has been used 
in folk medicine. Its leaves and seeds are known to treat 
lymphatitis, parotitis and struma (Kasahara & Henmi 
1986) while the stem bark has been used as antiseptic. 
The fruit juice possesses the properties as an anti-scurvy 
and expectorant for the relief of cough and sore throat. In 
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addition, its root extract is also used as an antipyretic and 
antitoxin agent (Wuttidhammavej 1997).
 It has been reported that G. dulcis contained at least 
four groups of chemical compounds including flavoniods 
(epicatechin, dulcisflavone, morelloflavone), benzophenone 
(garcinol and camboginol), xanthones (dulcisxanthone and 
garciniaxanthone) (Deachathai et al. 2008, 2006, 2005; 
Mahabusarakam et al. 2016) and benzophenone-xanthone 
dimer (garciduols A-C) (Iinuma et al. 1996). The amount of 
chemical constituents extracted from G. dulcis depended on 
the part of the plant specimens and the purified procedure.
 Some of isolated phenolic compounds from G. dulcis 
possess various biological activities. As previously reported, 
dulcisxanthone C-F and dulcinone from the flowers of G. 
dulcis showed a radical scavenging and antibacterial 
activity (Deachathai et al. 2006), dulcisxanthone G from 
the seed of G. dulcis showed an antibacterial and anti-
oxidative activity (Deachathai et al. 2008). Moreover, 
cambogin, camboginol, dulcisflavone, epicatechin and 
morelloflavone from the fruits of G. dulcis demonstrated 
the radical trapping and antibacterial activity (Deachathai 
et al. 2005).
 Morelloflavone, a biflavonoid comprising two 
covalently linked flavones, apigenin and luteolin, occurs 
in most Garcinia species (Ansari et al. 1976; Verbeek 
et al. 2004). Several biological actions have been 
reported for morelloflavone. Recently, we reported that 
in normotensive rats, morelloflavone could induce the 
dilatation of the isolated thoracic aorta via an endothelial-
dependent nitric oxide (NO) signaling pathway (Lamai et 
al. 2013). Morelloflavone inhibits secretory phospholipase 
A2 from human synovial, bee and snake venom (Gil 
et al. 1997; Pereañez et al. 2014). In animal models it 
has anti-inflammatory effects, with a potent inhibition 
of 12-O-tetradecanoylphorbol 13-acetate-induced ear 
inflammation in mice after topical administration (Gil et 
al. 1997). Morelloflavone inhibits vascular smooth muscle 
cell migration, invasion and lamellipodium formation 
in culture through activation of multiple migration-
related kinases, including focal adhesion kinase (FAK), 
Src, extracellular signal-regulated kinase (ERK) and 
RhoA (Pinkaew et al. 2009). The inhibition of RhoA and 
ERK pathways is also observed in vascular endothelial 
growth factor (VEGF)-stimulated human umbilical 
cord endothelial cells (Pang et al. 2009). Furthermore, 
morelloflavone inhibits neointimal proliferation in a 
mouse model of postangioplasty restenosis (Pinkaew et 
al. 2009). Morelloflavone inhibits HMG-CoA reductase 
leading to a decrease in de novo cholesterol synthesis 
(Tuansulong et al. 2011). Oral morelloflavone therapy for 
8 months significantly reduced the atherosclerotic areas 
of the mouse aortae (a 26% reduction), without changing 
plasma lipid profiles in Ldlr−/ − Apobec1−/− mice (Pinkaew 
et al. 2012). Despite these reports of various effects of 
morelloflavone on vascular and inflammatory functions, 
the effect on cardiovascular and renal functions in a model 
of hypertension with inflammatory involvement, the two-
kidneys- one-clip rat model (2K1C), has not been reported.
 The 2K1C model involves unilateral stenosis of the 
renal artery leading to a permanent reduction in renal 
perfusion pressure and renal blood flow (RBF) in one 
kidney (Goldblatt et al. 1934). The resulting hypertension 
is dependent upon activation of the renin angiotensin 
system (RAS), which plays an important role in the control 
of cardiovascular homeostasis affecting both arterial blood 
pressure (AP) and fluid volume. Angiotensin II, the main 
effector molecule of the RAS plays a pivotal role in this 
model by increasing in total peripheral resistance (TPR) 
and AP (Navar et al. 1998). The 2K1C model also shows 
impaired endothelial-dependent vasodilatation (Callera 
et al. 2000). Acute treatment with flavonoids, quercetin 
and ascorbic acid, improves endothelium-dependent 
vasodilatation in 2K1C rats (Choi et al. 2016).
 Renal function is also altered in 2K1C model, stenosis 
of one renal artery results in an immediate fall in RBF and 
glomerular filtration rate (GFR) to that kidney. Three weeks 
after renal stenosis, the stenotic kidney shows reduced RBF 
and GFR, whereas the contralateral kidney has a tendency 
toward reduced GFR in spite of unchanged RBF (Oliveira-
Sales et al. 2016). However, RBF and GFR of the non-clipped 
kidney are similar to that found in normotensive controls by 
four weeks despite the higher AP, renal vascular resistance 
(RVR) and angiotensin II level (Anderson et al. 1985; 
Martinez-Maldonado 1994). 
 The baroreflex is one of the body’s homeostatic 
mechanisms to modulate blood pressure. Baroreflex 
sensitivity (BRS) is impaired in animals (Gao et al. 
2002) and patients (Maliszewska-Scislo et al. 2008) 
with renovascular hypertension. Nicotinamide adenine 
dinucleotide phosphate [NAD(P)H] oxidase seems to play 
an important role in the blunted BRS in the 2K1C model, 
through increased reactive oxygen species (ROS), mainly 
superoxide anion, production (Botelho-Ono et al. 2011). 
Furthermore, the effect of endothelial modulation of 
endothelium-derived NO is impaired in 2K1C hypertension 
and the responsible mechanism is related to an increase in 
production of superoxide anions by NADH/NADPH oxidase 
(Choi et al. 2014).
 Against this background of increased ROS signaling 
and impaired NO function in 2K1C rats, this study aimed 
to investigate the diuretic and hypotensive effects of 
morelloflavone in anesthetized normotensive and 2K1C 
hypertensive rats. The vasorelaxant signaling mechanisms 
of morelloflavone action were also investigated in isolated 
thoracic aorta of both 2K1C and SO rats using specific 
inhibitors.
MATERIALS AND METHODS
EXTRACTION OF MORELLOFLAVONE FROM 
G. DULCIS FRUITS
The fresh ripe fruits of G. dulcis were collected from 
Songkhla province, Thailand. The voucher specimen has 
been deposited at the Herbarium of Prince of Songkla 
University, Thailand. The fruits were washed and chopped 
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into small pieces and then immersed in acetone for 5 
days at room temperature. Acetone was removed by 
evaporation to give a liquid extract that was partitioned 
with hexane follow by ethyl acetate to give a solid extract. 
Then, the solid was further fractionated by dissolving in 
dichloromethane (CH2Cl2). The CH2Cl2 soluble fraction 
was further fractionated by column chromatography to give 
morelloflavone as previously described by Deachathai et 
al. (2005). Morelloflavone was firstly isolated in 1976 by 
Ansari et al. and its structure was illustrated in Figure 1.
from surrounding connective tissues and a U-shaped silver 
clip with a 0.20 mm gap was placed around it close to the 
junction with the abdominal aorta. The free edges of the 
clip were compressed firmly to prevent dislodging. At the 
end of surgery, the muscle and skin layer were sutured 
separately with catgut and silk No. 4/0, respectively. The 
SO included the entire surgery with the exception of renal 
artery clipping. At the end of the surgery, all animals 
received a single dose of ampicillin (50 mg/kg BW, i.m.) 
injection and were allowed to recover in separate cages for 
2-3 h under an angle poise lamp and remained untouched 
for 4 weeks afterward in order to develop hypertension.
EXPERIMENTAL PROTOCOL FOR THE STUDY OF RENAL 
CLEARANCE AND BARORECEPTOR REFLEX
Four weeks after the operation, renal clearance and BRS 
were studied in one cohort of animals (n=6). The rats 
were anesthetized with pentobarbital sodium (60 mg/kg 
BW i.p.; an additional dose was given when necessary) 
and placed on a thermostatically-controlled heated table 
to maintain body temperature at 37ºC. A tracheotomy was 
performed and the left carotid artery was cannulated, using 
polyethelene tube (PE-50) filled with heparinized 0.9% 
NaCl and connected to a pressure transducer, coupled to 
a PowerLab system (ADInstruments, Colorado Springs, 
CO, USA), to measure AP and heart rate (HR) and for blood 
sampling. The right jugular vein was cannulated, using 
PE-50, and infused with clearance markers containing 
1% inulin (Sigma Chemical Co., St. Louis, MO, USA) 
and 0.5% p-amino-hippuric acid (PAH) (Sigma Chemical 
Co., St. Louis, MO, USA) dissolved in 0.9% NaCl at a 
rate of 1.6 mL/h/100g BW. Via a suprapubic midline 
incision, the left and right ureters were cannulated, using 
PE-10 connected to PE-50 for urine sample collection. 
After 45 min equilibration, morelloflavone dissolved in 
dimethylsulfoxide (DMSO) (Sigma Chemical Co., St. Louis, 
MO, USA) was given via the jugular vein as a bolus injection 
(0.1 mg/kg BW; volume of injection was 0.05 mL/100g 
BW) and then followed by continuous infusion at the rate 
of 5 mg/min/kg BW along with the clearance markers. This 
experimental dose of morelloflavone was chosen base on 
the minimal effective dose of a specific angiotensin II 
receptor antagonist, candesartan (Hiranyachattada et al. 
2005). The same amount of DMSO was given as vehicle 
in both SO and 2K1C groups. To determine the renal 
clearance, three consecutive 20 min urine collections were 
made during the 60 min of experimental period. An arterial 
blood sample (400 μL) was taken at the mid-point of the 
first and third urine collecting period. A small amount of 
the blood sample was used to determine the hematocrit 
by the microcapillary method and the remainder was 
centrifuged and the plasma was collected for determination 
of the concentrations of inulin and PAH. Blood cells were 
re-suspended in 200 μL 0.9% NaCl and returned to the 
animal via the right jugular vein. 
 Urine flow rate was determined gravimetrically by 
collecting urine into pre-weighed tubes and assuming a 
FIGURE 1. Chemical structure of morelloflavone purified from 
Garcinia dulcis fruits, a biflavonoid comprising two colavently 
linked flavones, apigenin and luteolin (Molecular formula 
C
30
H20O11, Molecular weight 556) (Ansari et al. 1976)
ANIMALS AND EXPERIMENTAL DESIGN
Male Wistar rats (body weight 175±4 g, n=84) were 
obtained from the Southern Laboratory Animal Facility 
(Prince of Songkla University, Thailand). Rats were 
housed under control conditions (temperature 23-24°C; 
humidity 50-55%; lighting 0600-1800 h), fed a laboratory 
diet containing 34.2 mmol sodium chloride/kg dry weight 
food and were allow free access to reverse osmosis water. 
All experiments were approved by the Prince of Songkla 
University Animal Ethics Committee (Reference No. 
31/2014). 
 The study consisted of in vivo and in vitro parts. The in 
vivo part (n=24) consisted of four groups of rats including 
vehicle-treated sham operation (SO), morelloflavone-
treated SO, vehicle-treated 2K1C and morelloflavone-
treated 2K1C group (n=6, ea). For in vitro part (n=60), 
the concentration-response of morelloflavone in isolated 
aortic rings from 2K1C and SO rats were examined in the 
absence (n=6, ea) and in the presence of the four specific 
inhibitors (n=6, ea). 
ESTABLISHMENT OF 2K1C HYPERTENSIVE RAT
The rats were anaesthetized with a single dose of 
pentobarbital sodium (50 mg/kg BW i.p.; CEVA Santé 
Animal, Brussels, Belgium). Only the deep sedated animals 
were gone through the following surgical protocol; the 
left kidney was exposed through a 1 cm retroperitoneal 
incision, the left renal artery was then exposed and cleared 
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density of 1 g/mL. The PAH and inulin concentrations, 
either in plasma or urine samples, were determined by a 
spectrophotometric method according to Smith et al. (1954) 
and Davidson and Sackner (1963), respectively. Plasma 
and urine osmolality POsm and UOsm were measured by 
using Micro-Osmometer (Fiske Model 210, USA) and then 
osmolar and negative free water clearance (COsm and 
TCH2O) were calculated.
 The BRS determination was performed after the 60 
min of renal clearance study by measuring HR and AP 
before and after acute injection of the two vasoactive 
drugs, phenylephrine (PE) (Sigma Chemical Co., St. 
Louis, MO, USA), a specific a1 receptor agonist and sodium 
nitroprusside (SNP) (Sigma Chemical Co., St. Louis, MO, 
USA), a nitric oxide donor, at the same doses of 1, 2, 4, 8, 
16 and 32 μg/kg BW.
 At the end of experiment, rats were killed by 
intravenous injection of saturated MgSO4. Both kidneys 
were removed, decapsulated, dried on blotting paper and 
weighed. The heart was also removed and weighed after 
carefully clearing away blood vessels, fat and connective 
tissues. The organ weight to total body weight ratio was 
calculated.
PREPARATION OF ISOLATED THORACIC AORTIC RINGS
After 4 weeks, separate groups of 2K1C and SO rats (n=6, 
ea) were anesthetized with pentobarbital sodium (60 
mg/kg, i.p.) and sacrificed by decapitation. The thoracic 
aorta was dissected and cut into four ring segments 
approximately 5 mm in length each (two intact- and two 
denuded-endothelial rings). The denuded rings were 
performed by mechanical removal of endothelium. The 
rings were mounted in 20 mL organ baths containing 
37°C Krebs Henseleit solution which was composed of 
(mM) 118.41 NaCl, 4.6 KCl, 1.12 MgSO4.7H2O, 1.18 
KH2PO4, 1.9 CaCl2, 25.0 NaHCO3 and 11.66 D-glucose. 
The pH of solution was maintained at 7.4 by continuous 
aeration with 95% O2 and 5% CO2. The resting tension 
of 1 g was set and the tension changes during the courses 
of experiment were recorded using force displacement 
transducer (Model FT03, Grass Instrument Co., Quincy, 
MA, USA) connected to PowerLab system (ADInstruments, 
USA). Endothelial function of aortic rings was tested by the 
addition of 10-5 M acetylcholine (ACh) (Sigma Chemical 
Co., St. Louis, MO, USA) into the 10-7 M PE precontracted 
rings. The 80% relaxation was accepted and considered as 
an intact endothelium and the disappearance of relaxation 
was considered denuded endothelium (Molina et al. 1992).
CONCENTRATION-RESPONSE CURVE 
OF MORELLOFLAVONE
After 45 min equilibration, aortic rings (both intact and 
denuded endothelium) from 2K1C and SO rats were 
precontracted by addition of 10-7 M PE. When the maximal 
contraction response developed, the tension was recorded. 
Either morelloflavone or vehicle (0.1% DMSO) was added 
cumulatively, allowing the final concentration to be 10-13-
10-5 M. Subsequent concentrations were added after the 
maximal response by the previous concentration developed 
and recorded.
EFFECT OF SPECIFIC INHIBITORS ON VASORELAXATION 
RESPONSE OF MORELLOFLAVONE
After 15 min equilibration, the intact-endothelial aortic 
rings from 2K1C and SO rats were incubated with each 
specific inhibitor for 30 min before precontraction with 
10-7 M PE. The doses of each inhibitor were 10-4 M Nω-
Nitro-L-arginine methyl ester (L-NAME) (Sigma Chemical 
Co., St. Louis, MO, USA), 10-6 M indomethacin (Sigma 
Chemical Co., St. Louis, MO, USA), 10-5 M glibenclamide 
(Sigma Chemical Co., St. Louis, MO, USA) and 10-3 M 
tetraethyl ammonium (TEA) (Sigma Chemical Co., St. 
Louis, MO, USA). Then, either morelloflavone (10-13-10-8 M) 
or vehicle (0.1% DMSO) was added cumulatively after the 
maximal contraction was developed and 5-7 min sustained. 
Subsequent concentrations were added after the maximal 
response by the previous concentration developed and 
recorded. 
CALCULATIONS AND STATISTICAL ANALYSES
Inulin, PAH and osmolar clearance were calculated 
according to clearance equation ( ×UX/PX), free water 
clearance (CH2O) as -COsm and negative free water 
clearance (TCH2O) as COsm- , where  = urine flow 
rate, UX and PX = urine and plasma concentration of 
either inulin, PAH or urine and plasma osmolality, COsm 
= osmolar clearance. Clearance of inulin and PAH were 
taken as the indices of GFR and effective renal plasma flow 
(ERPF), respectively. COsm and TCH2O were the indices of 
urinary electrolyte excretion and free water reabsorption, 
respectively. Mean arterial pressure (MAP) was determined 
from diastolic blood pressure (DBP) + 1/3 pulse pressure 
(PP). Renal vascular resistance (RVR) was computed from 
∆MAP/ERPF and expressed as resistance unit (RU). BRS 
was computed from ∆HR/∆MAP. All data were expressed 
as the mean ± S.E.M. Comparisons between the mean 
values were performed with one-way analysis of variance 
(ANOVA) (GraphPad Prism 5, San Diego, CA, USA) followed 
by Tukey post hoc test. A p<0.05 was considered to be 
statistically significant difference.
 For in vitro study, the degree of vasorelaxation in each 
experiment were expressed as a %relaxation from PE (10-7 
M) precontraction tension. All values were expressed as 
mean ± S.E.M. Significant difference between the group 
means was determined using ANOVA followed by Student-
Newman Keuls post hoc test or student t-test. The negative 
logarithm (pD2) and half maximal effective concentration 
(EC
50
) values were calculated using GraphPad Prism 5 
(San Diego, CA, USA). Statistical significance of the mean 
differences were accepted when p<0.05.
  1483
RESULTS
EFFECTS OF MORELLOFLAVONE ON ARTERIAL BLOOD 
PRESSURE AND HEART RATE
As shown in Figure 2(a)-2(d), four weeks after experimental 
renal stenosis, the systolic blood pressure (SBP), DBP, PP and 
MAP in 2K1C rats were significantly higher than in those 
of SO rats (SBP; 185±4 vs. 155±2, DBP; 136±1 vs. 125±4, 
PP; 49±4 vs. 30±2 and MAP; 152±1 vs. 135±3 mmHg, 
respectively, p<0.05). The resting HR of 2K1C group was 
not significantly different from SO (208±6 vs. 213±3 bpm). 
When morellofavone was given in 2K1C rats, the SBP, DBP 
and MAP decreased significantly when compared to vehicle-
treated 2K1C rats (SBP; 165±4 vs. 185±4, DBP; 126±5 vs. 
136±1 and MAP; 138±6 vs. 152±1 mmHg, respectively, 
p<0.05) whereas the PP and HR did not alter statistically 
(PP; 41±4 vs. 49±4 mmHg and HR; 207±5 vs. 208±6 bpm). 
The treatment of either morelloflavone or its vehicle in SO 
rats showed no significant alterations in SBP (155±2 vs. 
155±2 mmHg), DBP (121±2 vs. 125±4 mmHg), PP (35±2 
vs. 30±2 mmHg), MAP (132±2 vs. 135±3 mmHg) and 
HR (203±5 vs. 213±3 bpm), respectively. The significant 
higher AP observed in 2K1C than SO rats suggested the 
successful development of hypertensive model in this 
study. Morelloflavone treatment lowered AP observed in 
2K1C rats towards the level in SO.
EFFECTS OF MORELLOFLAVONE ON RENAL FUNCTIONS
As shown in Figure 3(a)-3(h), 2K1C rats had significantly 
higher renal vascular resistance (RVR), urine flow rate 
( ), osmolar clearance (COsm) and negative free water 
clearance (TCH2O) when compared to SO rats (RVR; 70±6 
vs. 39±4 RU, ; 18.2±3.9 vs. 9.6±0.9 mL/min/g KW, COsm; 
75.6±5.8 vs. 52.1±3.8 mL/min/g KW and TCH2O; 56.2±5.4 
vs. 41.0±3.6 mL/min/g KW, respectively, p<0.05) but had a 
significantly lower ERPF (2.29±0.25 vs.3.63±0.36 mL/min/g 
KW, p<0.05). However, there was no significant difference 
of GFR, urine and plasma osmolality (UOsm and POsm) 
between 2K1C and SO rats (GFR; 1.48±0.16 vs. 1.43±0.12 
mL/min/g KW, UOsm; 1240±49 vs. 1425±46 mOsm/kg H2O 
and POsm; 330±5 vs. 326±3 mOsm/kg H2O, respectively). 
 When morelloflavone was given in 2K1C rats, 
a significant decrease in RVR, UOsm and TCH2O were 
observed when compared to vehicle-treated 2K1C rats 
(RVR; 45±6 vs. 70±6 RU, UOsm 670±84 vs. 1240±49 
mOsm/kg H2O and TCH2O; 40.4±3.8 vs. 56.2±5.4 mL/min/g 
KW, respectively, p<0.05). However, the ERPF,  and COsm 
were found to be significantly higher (ERPF; 3.44±0.49 vs. 
2.29±0.25 mL/min/g KW, ; 42.0±9.4 vs. 18.2±3.9 mL/
min/g KW and COsm; 106.3±11.4 vs. 75.6±5.8 mL/min/g 
KW, respectively, p<0.05). In addition, GFR and POsm were 
not significantly different between the two groups (GFR; 
1.48±0.16 vs. 1.35±0.12 mL/min/g KW and POsm; 317±4 
vs. 330±4 mOsm/kg H2O, respectively).
Values are mean±S.E.M.*
#p<0.05 compare with SO and 2K1C group, respectively (one-way ANOVA) 
FIGURE 2. Effects of morelloflavone (M) 0.1 mg/kg BW + 5 mg/min/kg BW on systolic blood pressure 
(SBP; a), diastolic blood pressure (DBP; b), pulse pressure (PP; c) and mean arterial blood pressure 
(MAP; d) in 2-kidneys-1-clip (2K1C) and sham operative (SO) group during clearance study 
(c) (d)
(a) (b)
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 The administration of morelloflavone in SO rats 
resulted in a significant increase in GFR,  and COsm but 
a decrease in UOsm when compared to vehicle-treated 
SO rats (GFR; 1.72±0.14 vs. 1.43±0.12 mL/min/g KW, ; 
44.7±4.3 vs. 9.6±0.9 mL/min/g KW, COsm; 87.5±7.2 vs. 
52.8±5.6 mL/min/g KW and UOsm; 613±41 vs. 1425±46 
mOsm/kg H2O, respectively, p<0.05) while the ERPF, RVR, 
POsm and TCH2O remained unaltered (ERPF; 3.96±0.28 vs. 
3.63±0.36 mL/min/g KW, RVR; 35±2 vs. 39±4 RU, POsm; 
321±2 vs. 326±3 mOsm/kg H2O and TCH2O; 31.7±3.8 vs. 
Values are mean ± S.E.M.*
#p<0.05 compare with SO and 2K1C group, respectively (one-way ANOVA)
FIGURE 3. Effects of morelloflavone (M) (0.1mg/kg BW bolus + 5 mg/min/kg BW) on mean arterial blood pressure 
(MAP; a), effective renal plasma flow (ERPF; b), renal vascular resistance (RVR; c), glomerular filtration rate 
(GFR; d), urine flow rate ( ; e), urine osmolality (UOsm; f), osmolar clearance (COsm; g) and negative free 
water clearance (TCH2O; h), in 2-kidneys-1-clip (2K1C) and sham operative (SO) group during clearance study
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40.0±3.4 mL/min/g KW, respectively). All the stated data 
suggested that the decreased RBF of 2K1C rats was due 
to the renal vasoconstriction. Renal tubular water and 
electrolytes excretion of 2K1C rats were also impaired. 
Morelloflavone treatment can correct the impairment of 
both RBF and renal electrolytes excretion in 2K1C rats. 
The diuretic effect of morelloflavone was also observed 
in SO rats. 
EFFECTS OF MORELLOFLAVONE ON 
BAROREFLEX SENSITIVITY (BRS)
As shown in Figure 4(a) and 4(b), the BRS responses 
to the six doses of PE (1, 2, 4, 8, 16 and 32 mg/kg BW) 
intravenous injection in 2K1C were significantly lowered 
when compared to those of SO rats (-0.11±0.05 vs. 
-0.73±0.22, -0.13±0.04 vs -0.55±0.10, -0.22±0.05 vs. 
-0.55±0.10, -0.21±0.03 vs. -0.63±0.05, -0.20±0.03 vs. 
-0.78±0.08 and -0.23±0.04 vs. -1.03±0.08 bpm/mmHg, 
respectively, p<0.05). There was no significant difference 
in respective BRS to PE between SO with morelloflavone-
treated and vehicle-treated rats. Morelloflavone treatment 
significantly resulted in a higher BRS in 2K1C in 
comparison to vehicle-treated rats at the respective doses 
of PE injection (-0.43±0.06 vs. -0.11±0.05, -0.42±0.09 vs. 
-0.13±0.04, -0.43±0.11 vs. -0.22±0.05, -0.37±0.04 vs. 
-0.21±0.03, -0.53±0.14 vs. -0.20±0.03 and -0.77±0.15 vs. 
-0.23±0.04 bpm/mmHg, respectively, p<0.05). 
 The BRS to the six doses of SNP (1, 2, 4, 8, 16 
and 32 mg/kg BW) intravenous injection in 2K1C rats 
were significantly lowered when compared to those 
of SO rats (-0.04±0.02 vs. -0.32±0.05, -0.10±0.04 vs. 
-0.34±0.08, -0.09±0.04 vs. -0.28±0.04, -0.11±0.03 vs. 
Values are mean ± S.E.M.* 
#p<0.05 compared with SO and 2K1C group at the respective concentrations of phenylephrine (PE) or sodium nitroprusside (SNP) (one-way ANOVA)
FIGURE 4. Baroreflex sensitivity (BRS) in response to either phenylephrine (PE; left panal) or sodium nitroprusside 
(SNP; right panal) in 2-kidneys-1-clip (2K1C) and sham operative (SO) group during treatment with morelloflavone 
(M) (0.1mg/kg BW + 5 mg/min/kg BW). BRS was computed from ∆HR/∆MAP
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TABLE 1. Comparison of body weight (BW), left and right kidney weight (KW), cardiac mass and hematocrit between sham 
operation (SO) and 2-kidneys-1-clip (2K1C) rats which treated with either morelloflavone (M) or vehicle (V)
SO+V SO+M 2K1C+V 2K1C+M
Number of rats
Pre-BW (g)
Post-BW (g)
rBW (g)
Left KW (g)
Left KW/BW (%)
Right KW (g)
Right KW/BW (%)
Cardiac mass (g)
Cardiac mass/BW (%)
Hematocrit (%)
6
206 ± 4
388 ± 3
182 ± 6
 1.05 ± 0.02
 0.27 ± 0.01
 1.18 ± 0.02
 0.30 ± 0.01
 1.06 ± 0.02
 0.27 ± 0.01
 49.2 ± 0.9
6
202 ± 3
 383 ± 10
 181 ± 10
 0.99 ± 0.02
 0.26 ± 0.01
 1.05 ± 0.03
 0.27 ± 0.01
 1.00 ± 0.03
 0.26 ± 0.01
 52.0 ± 0.4
6
194 ± 9
 379 ± 20
 185 ± 19
 0.28 ± 0.07*
 0.07 ± 0.01*
 1.46 ± 0.07*
 0.39 ± 0.02*
 1.23 ± 0.12*
 0.32 ± 0.02*
 51.6 ± 1.3
6
186 ± 9
 358 ± 13
 172 ± 19
 0.23 ± 0.02*
 0.06 ± 0.01*
 1.25 ± 0.03*
 0.35 ± 0.01*
 1.22 ± 0.02*
 0.34 ± 0.01*
 51.6 ± 0.8
Data are mean ± S.E.M. 
*p<0.05 compare with respective SO group (Student t-test)
-0.28±0.03, -0.10±0.02 vs. -0.29±0.04 and -0.12±0.02 
vs. -0.34±0.06 bpm/mmHg, respectively, p<0.05). There 
was no significant difference in BRS between SO with 
merelloflavone-treated and vehicle-treated rats at the 
respective doses of SNP. 
 Morelloflavone treatment significantly resulted a 
higher BRS in 2K1C in comparison to vehicle-treated 
rats at the respective doses of SNP injection (-0.44±0.07 
vs -0.04±0.02, -0.31±0.06 vs. -0.10±0.04, -0.21±0.03 vs. 
-0.09±0.04, -0.20±0.04 vs. -0.11±0.03, -0.21±0.03 vs. 
-0.10±0.02 and -0.23±0.03 vs. -0.12±0.02 bpm/mmHg, 
respectively, p<0.05. The above data suggested that 
the BRS were blunted in 2K1C rats and morelloflavone 
treatment can restore this BRS impairment.
CHANGES IN KIDNEY WEIGHT, CARDIAC MASS 
AND BODY WEIGHT
As shown in Table 1, the left clipped kidneys of vehicle-
treated 2K1C groups atrophied while the right unclipped 
kidneys hypertrophied when compared with the respective 
ipsilateral kidneys of vehicle-treated SO groups (left KW/
BW; 0.07±0.01 vs. 0.27±0.01% and right KW/BW; 0.39±0.02 
vs. 0.30±0.01%, respectively, p<0.05). Cardiac mass/
BW of vehicle-treated 2K1C significantly increased in 
comparison to that of vehicle-treated SO rats (0.32±0.02 
vs. 0.27±0.01%, respectively, p<0.05). Other parameters 
including the pre- and post-body weight, body weight 
changes and hematocrit values measuring during clearance 
study were not significantly different between among those 
four groups of rats. 
VASORELAXANT EFFECTS OF MORELLOFLAVONE IN 
ISOLATED THORACIC AORTIC RINGS
As shown in Figure 5(a), the addition of the cumulative 
doses of morelloflavone (10-13-10-5 M) significantly relaxed 
the PE-preconstracted endothelial intact aortic rings in a 
concentration-dependent manner with the pD2 = 6.99±0.91 
(EC
50
 = 102.8 nM) of 2K1C and the pD2 = 9.92±0.86 (EC50 = 
0.52 nM) of SO rats (p<0.05). Denudation of the functional 
endothelium completely abolished morelloflavone-induced 
vasorelaxation in both 2K1C and SO as shown in Figure 
5(b). These data indicated the vasorelaxation effect of 
morelloflavone which might be endothelium dependent. 
EFFECT OF L-NAME ON MORELLOFLAVONE-INDUCED 
VASORELAXATION
Pretreatment of the endothelium-intact aortic rings with 
10-4 M L-NAME significantly and completely abolished (10-12
-10-8 M) morelloflavone-induced vasorelaxation in both SO 
and 2K1C rats as shown in Figure 6(a) and 6(b). The data 
suggested that vasorelaxant effect of morelloflavone might 
involve in endothelial NO signaling pathway.
EFFECTS OF INDOMETHACIN, GLIBENCAMIDE AND TEA ON 
MORELLOFLAVONE-INDUCED VASORELAXATION
As shown in Figure 6(d) and 6(h), the %relaxation of 
aortic rings from SO rats in response to the addition of 
morelloflavone (10-13 and 10-12 M) in the presence of 
10-6 M indomethacin and 10-5 M glibencamide were 
found to be significantly decreased in comparison to in 
the absence of indomethacin (10-13 M morelloflavone; 
3.3±0.9 vs. 20.1±3.1% and 10-12 M; 17.7±4.1 vs. 34.8±3.4 
%, respectively, p<0.05) and glibenclamide (10-13 M 
morelloflavone; 5.9±1.4 vs. 20.0±4.2 % and 10-12 M; 
19.9±4.1 vs. 33.6±3.6 %, respectively, p<0.05). The 
%relaxation in response to morelloflavone (10-13-10-11 M) 
in the presence of 10-3 M TEA were found to be significantly 
decreased in comparison to in the absence of this inhibitors 
(10-13 M morelloflavone; 2.2±1.3 vs. 20.0±4.2, 10-12 M; 
12.4±4.5 vs. 33.6±3.6 and 10-11 M; 27.4±5.8 vs. 45.2±4.6%, 
respectively, p<0.05) as shown in Figure 6(f). The effects of 
these three inhibitors at the lower doses of morelloflavone-
induced vasorelaxation occurred only in SO but not 2K1C 
(Figure 6(c), 6(e) and 6(g)), suggested that the mechanism 
of morelloflavone actions may involve PGI2, KATP and KCa2+ 
signaling pathways. 
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DISCUSSION
Four weeks after experimental renal artery stenosis, 
SBP, DBP, PP and MAP of 2K1C measuring under 
pentobarbitone sodium anesthetization via left carotid 
artery were significantly higher than those of SO. 
The results suggested the successful development of 
hypertensive model in this study. This was also supported 
by the significant increase in the cardiac mass and the 
atrophy of the clipped left kidney with the hypertrophy 
of the non-clipped right kidney of 2K1C when compared 
to SO rats (Table 1). One of the important pathological 
mechanisms in hypertension development involves 
the abnormality of RAS in which the high circulating 
angiotensin II directly binds to the receptor at vascular 
smooth muscle and then increases the total peripheral 
resistance and raises blood pressure observed in both 
awaken and under anesthesia rats (Goldblatt et al. 1934; 
Murphy et al. 1984; Navar et al. 1998). The higher renal 
vascular resistance seen in 2K1C than in SO (Figure 
3(c)), in part, positively supported an increase in total 
vascular resistance by increased angiotensin II level. 
Moreover, the role of oxidative stress in generation and 
maintenance of arterial hypertension has been reported 
in 2K1C model (Oliveira-Sale et al. 2008). It was shown 
that an increase in circulating angiotensin II can activate 
the vascular smooth muscle NAD(P)H oxidase which is an 
important cellular source of ROS (Griendling et al. 1994). 
In addition, the rise in superoxide level decreases the 
bioavailability of NO and contributes to the maintenance 
of elevated peripheral resistance (Cai & Harrison 2000).
 Morelloflavone administration in 2K1C rats in this 
study significantly lowered SBP, DBP and MAP which was 
not found in SO rats (Figure 2). These results suggested 
the pronounced hypotensive effect of morelloflavone in 
hypertension rather than in normotension. Experiments 
in isolated thoracic aorta showed the vasorelaxant 
mechanism of morelloflavone in 2K1C is likely to be 
endothelium-dependent and involves NO signaling 
pathway similar to those of SO rats (Figures 5 and 6(a), 
6(b)) even though the more endothelium damage occurred 
in 2K1C than SO (Figure 5(a) and their EC
50 
values). 
The other signaling pathways which may contribute 
to the vasorelaxant mechanism of morelloflavone in 
normotension included the operation of KCa2+, KATP 
channels or endothelial derived hyperpolarizing factor 
(EDHF) pathway which were unlikely to occur in 2K1C 
hypertension (Figure 6(c)-6(h)).
 Thus, the marked hypotensive effect of morelloflavone 
seen in 2K1C rats may be due to its both antioxidant and 
NO-dependent vasorelaxant property. The reason that this 
hypotensive effect was not obviously seen in SO rats may 
be the well regulation of baroreceptor reflex in response 
to the chosen dose of morelloflavone (0.1 mg/kg+5 mg/
kg/min). This dose was the minimal hypotensive dose 
comparable to candesartan, an angiotensin II receptor 
blocker previously reported (Hiranyachattada et al. 
2005). At this minimal hypotensive effective dose of 
morelloflavone selected in this study, taken together with 
the more impaired BRS of 2K1C than SO, the pronounced 
reduction in arterial blood pressure was then observed.
 The BRS responses to PE and SNP in 2K1C were 
less than SO rats suggested the blunt BRS (Figure 4) and 
morelloflavone could restore these impaired BRS. The 
responsible mechanism may occur via its antioxidant 
property which enhanced NO bioavailability since it is 
reported that an acute infusion antioxidant such as vitamin 
C or apocyanin, a NADPH oxidase inhibitor, can restore 
BRS in 2K1C rats to the values that resembles to those 
of normotensive rats (Botelho-Ono et al. 2011). Acute 
superoxide scavenging is also reported to restore the 
depressed BRS in 2K1C hypertensive rats (Botelho-Ono 
et al. 2011). 
 Beside  the  marked hypotensive  effect  of 
morelloflavone in 2K1C rats, its diuretic effect was also 
investigated. While there was no change in GFR of 2K1C 
when compared to SO rats, RVR, , COsm and TCH2O 
Values are mean±S.E.M of the percentage relaxation from 10-7M phenylephrine (PE) pre-contraction* 
#p<0.05 compare with respective vehicle groups and SO+M group, respectively (one-way ANOVA) 
FIGURE 5. Effects of morelloflavone (M) or vehicle (DMSO) on vasorelaxation of intact endothelium (a) or 
denuded (b) thoracic aorta from 2-kidneys-1-clip (2K1C) or sham operative (SO) group
(a)  Intact endothelium (b)  Denuded endothelium
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were significantly higher. These findings are consistent 
with previous reports in which the GFR of 2K1C rats is 
similar to normotensive controls within 4 weeks after 
the renal artery clipping despite the increasing in AP, 
RVR and angiotensin II level (Anderson et al. 1985; 
Martinez-Maldonado1991). The higher urine flow in 
2K1C may be due to an abnormal tubular electrolyte 
and water reabsorption in response to high circulating 
level of angiotensin II or NO similar to experimented in 
normotension. In normotensive rats, angiotensin II exerts 
Values are mean ± S.E.M.* 
#p<0.05 compare with vehicle and morelloflavone (M) group, respectively (one-way ANOVA) 
FIGURE 6. Effects of morelloflavone (M) on vasorelaxation of intact endothelium thoracic aorta from 2-kidneys-1-clip (2K1C; 
left panels) and sham operation (SO; right panels) group in the presence of specific inhibitors; 10-4 M L-NAME (a, b), 10-6 M 
indomethacin (c, d), 10-3 M TEA (e, f) and 10-5 M glibenclemide (g, h)
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biphasic effect in which low dose (10-12-10-9 M) when 
appling to either luminal or peritubular side stimulates 
renal tubular fluid absorption while the higher dose 
(10-7-10-6 M) causes inhibition (Harris & Young 1997). 
Moreover, addition of SNP, a NO donor, inhibits renal 
proximal fluid reabsorption (Eitle et al. 1998). Thus, the 
inhibition of tubular electrolytes and water reabsorption 
due to the higher levels of angiotensin II and perhaps 
NO may contribute to the high urine flow rate and high 
osmolar clearance of 2K1C.
 The diuretic effect of morelloflavone was not only 
observed in normotensive SO but also in hypertensive 
2K1C with the similar degree, however, the mechanisms 
of diuretic action might be different in some extent. After 
morelloflavone administration in SO rats, GFR, urine 
flow rate and osmolar clearance increased significantly 
when compared to the vehicle-treated SO rats while other 
renal function parameters remained unaltered. These 
findings suggested the diuretic effect of morelloflavone 
in normotension may exert via both glomerular and 
tubular function. Morelloflavone relaxes vascular smooth 
muscle of the thoracic aorta isolated from normotensive 
rats ((Lamai et al. 2013), thus, it is likely that it may 
relax the afferent arterioles resulting in an increased 
GFR. It is also feasible that morelloflavone might exert 
its diuretic effect by inhibition of epithelial electrolyte 
transport in either proximal or distal part of the nephron. 
Other plant flavonoids that elicit renal vasodilation and 
increase urinary sodium and water excretion including 
the flavoniods extracted from Clerodendron trichotomum 
and Spergularia purpurea (Jouad et al. 2001; Lu et al. 
1994).
 The similar diuretic action of morelloflavone was 
observed by an increase in and COsm in 2K1C (Figure 
3(e) and 3(g)) but not by a significant GFR alteration 
(Figure 3(d)). These indicated the inhibition of renal 
tubular electrolyte reabsorption by morelloflavone rather 
than its increased filtered load action like those in SO rats. 
In addition, in SO rats, morelloflavone did not alter tubular 
free water reabsorption which contradicted to 2K1C 
rats (Figure 3(h)) suggesting another different pathway 
of its diuretic action in hypertensive model. Distal 
tubular water reabsorption occurs mainly in response 
to antidiuretic hormone (ADH) action, so it is possible 
that morelloflavone can improve water reabsorption by 
increasing the expression of renal tubular water channel, 
aquaporin in this model.
CONCLUSION
This work is the first preliminary report of the diuretic and 
hypotensive effect of morelloflavone, a plant biflavonoid, in 
hypertensive rats. Its hypotensive effect and the restoration 
of an impaired BRS may occur via vasorelaxant property 
of morelloflavone that enhances NO bioavailability. The 
diuretic action of morelloflavone is likely to involve 
both increased glomerular filtration and deceased tubular 
reabsorption of electrolytes and water. 
ACKNOWLEDGEMENTS
This research was financially supported by the Higher 
Education Research Promotion and National Research 
University Project of Thailand, Office of the Higher 
Education Commission (SC75705685) and Prince of 
Songkla Ph.D. Scholarships, Prince of Songkla University, 
Hatyai, Songkhla, Thailand. We declare that we have no 
conflict of interest.
REFERENCES
Anderson, W.P., Kline, R.L. & Woods, R.L. 1985. Systemic 
and renal hemodynamic changes during unilateral renal 
arterial stenosis. American Journal of Physiology (Heart and 
Circulatory Physiology) 249: H956-H967.
Ansari, W.H., Rahman, W., Barraclough, D., Maynard, R. & 
Scheinmann, F. 1976. Biflavanoids and a flavanone chromone 
from the leaves of Garcinia dulcis (Roxb.) Kurz. Journal of 
the Chemical Society, Perkin Transactions 1 13: 1458-1463.
Botelho-Ono, M.S., Pina, H.V., Sousa, K.H.F., Nunes, F.C., 
Medeiros, I.A. & Braga, V.A. 2011. Acute superoxide 
scavenging restores depressed baroreflex sensitivity in 
renovascular hypertensive rats. Autonomic Neuroscience: 
Basic and Clinical 159: 38-44.
Cai, H. & Harrison, D.G. 2000. Endothelial dysfunction 
in cardiovascular diseases: The role of oxidant stress. 
Circulation Research 87: 840-844.
Callera, G.E., Varanda, W.A. & Bendhack, L.M. 2000. Impaired 
relaxation to acetylcholine in 2K1C hypertensive rat aortas 
involves an abnormal contribution of endothelial factors. 
General Pharmacology 34: 379-389.
Choi, S., Ryu, K.H., Park, S.H., Jun, J.Y., Shin, B.C., Chung, J.H. 
& Yeum, C.H. 2016. Direct vascular actions of quercetin in 
aorta from renal hypertensive rats. Research and Clinical 
Practice 35: 15-21.
Choi, S., Shin, H.R., Kim, S.H., Lee, M.J., Jun, J.Y., Kim, H.L., 
Chung, J.H. & Yeum, C.H. 2014. Effects of oxidative stress 
on endothelial modulation of contractions in aorta from renal 
hypertensive rats. Kidney Research and Clinical Practice 
33: 19-25.
Davidson, W.D. & Sackner, M.A. 1963. Simplification of 
anthrone method of the determination of inulin in clearance 
studies. The Journal of Laboratory and Clinical Medicine 
62: 351-356.
Deachathai, S., Phongpaichit, S. & Mahabusarakam, W. 2008. 
Phenolic compounds from the seeds of Garcinia dulcis. 
Natural Product Research 22: 1327-1332.
Deachathai, S., Mahabusarakam, W., Phongpaichit, S., Taylor, 
W.C., Zhang, Y.J. & Yang, C.R. 2006. Phenolic compounds 
from the flowers of Garcinia dulcis. Phytochemistry 67: 
464-469.
Deachathai, S., Mahabusarakam, W., Phongpaichit, S. & Taylor, 
W.C. 2005. Phenolic compounds from the fruit of Garcinia 
dulcis. Phytochemistry 66: 2368-2375.
Eitle, E., Hiranyachattada, S.,Wang, H. & Harris, P.J. 1998. 
Inhibition of proximal tubular fluid absorption by nitric oxide 
and atrial natriuretic peptide in rat kidney. American Journal 
of Physiology (Cell Physiology) 274: C1075-C1080.
Gao, S.A., Johansson, M., Rundqvist, B., Lambert, G., Jensen, 
G. & Friberg, P. 2002. Reduced spontaneous baroreceptor 
sensitivity in patients with renovascular hypertension. 
Journal of Hypertension 20: 111-116.
1490 
Gil, B., Sanz, M.J., Terencio, M.C., Gunaseqaran, R., Payá, M. 
& Alcaraz, M.J. 1997. Morelloflavone, a novel biflavonoid 
inhibitor of human secretory phospholipase A2 with anti-
inflammatory activity. Biochemical Pharmacology 53: 
733-740.
Goldblatt, H., Lynch, J., Hanzal, R.F. & Summerville, W.W. 1934. 
Studies on experimental hypertension. I. The production of 
persistent elevation of systolic blood pressure by means of 
renal ischemia. The Journal of Experimental Medicine 59: 
347-380.
Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D. & Alexander, 
R.W. 1994. Angiotensin II stimulates NADH and NADPH 
oxidase activity in cultured vascular smooth muscle cells. 
Circulation Research 74: 1141-1148.
Harris, P.L. & Young, J.A. 1977. Dose-dependent stimulation 
and inhibition of proximal tubular sodium reabsorption 
by angiotensin II in the rat kidney. European Journal of 
Physiology 367: 295-297.
Hiranyachattada, S., Saetew, S. & Harris, P.J. 2005. Acute 
effects of candesartan on rat renal haemodynamics and 
proximal tubular reabsorption. Clinical and Experimental 
Pharmacology and Physiology 32: 714-720.
Iinuma, M., Tisa, H., Ito, T., Tanaka, T. & Riswan, S. 1996. 
Three new benzophenone-xanthone dimmers from the root 
of Garcinia dulcis. Chemical and Pharmaceutical Bulletin 
44: 1744-1747.
Jouad, H., Lacaille-Dubois, M.A., Lyoussi, B. & Eddouks, M. 
2001. Effects of the flavonoids extracted from Spergularia 
purpurea Pers. on arterial blood pressure and renal 
function in normal and hypertensive rats. The Journal 
of Ethnopharmacology 76: 159-163.
Kasahara, S. & Henmi, S. 1986. Medical herb index in Indonesia. 
Jakarta: P.T. Esai Indonesia. p. 92.
Lamai, J., Mahabusarakam, W., Ratithammatorn, T. & 
Hiranyachattada, S. 2013. Effects of morelloflavone from 
Garcinia dulcis on vasorelaxation of isolated rat thoracic 
aorta. Journal of Physiological and Biomedical Sciences 
26: 13-17.
Lu, G.W., Miura, K., Yukimura, T. & Yamamoto, K. 1994. 
Effects of extracts from Clerodendron trichotomum on blood 
pressure and renal function in rats and dogs. The Journal of 
Ethnopharmacology 42: 77-82.
Mahabusarakam, W., Mecawun, P. & Phongpaichit, S. 2016. 
Xanthones from the green branch of Garcinia dulcis. Natural 
Product Research 30: 2323-2328.
Maliszewska-Scislo, M., Chen, H., Augustyniak, R.A., Seth, D. & 
Rossi, N.F. 2008. Subfornical organ differentially modulates 
baroreflex function in normotensive and two-kidney, one-
clip hypertensive rats. American Journal of Physiology 
(Regulatory, Integrative and Comparative Physiology) 295: 
R741-R750.
Martinez-Maldonado, M. 1991. Pathophysiology of renovascular 
hypertension. Hypertension 17: 707-719.
Molina, R., Hidalgo, A. & García de Boto, M.J. 1992. Influence 
of mechanical endothelium removal techniques and 
conservation conditions on rat aorta responses. Methods 
and Findings in Experimental and Clinical Pharmacology 
14: 91-96.
Murphy, W.R., Coleman, T.G., Smith, T.L. & Stanek, K.A. 1984. 
Effects of graded renal artery constriction on blood pressure, 
renal artery pressure, and plasma renin activity in Goldblatt 
hypertension. Hypertension 6: 68-74.
Navar, L.G., Zou, L., Thun, A.V., Wang, C.T., Imig, J.D. & 
Mitchell, K.D. 1998. Unraveling the mystery of Goldblatt 
hypertension. News in Physiological Sciences 13: 170-176.
Oliveira-Sale, E.B., Dugaich, A.P. & Abreu, N.P. 2008. Oxidative 
stress supports blood pressure and sympathetic activity 
in renovascular hypertension. The American Journal of 
Hypertension 21: 98-104.
Oliveira-Sales, E.B., Varela, V.A., Maquiqussa, E., Borges, F.T., 
Shimoura, C.G., Gomes, G., Campos, R.R. & Boim, M.A. 
2016. Renovascular hypertension: Effect of mesenchymal 
stem cells in the contralateral hypertensive kidney in rats. 
Clinical Experimental Hypertensions 38: 586-593.
Pang, X., Yi, T., Yi, Z., Cho, S.G., Qu, W., Pinkaew, D., Fujise, K. 
& Liu, M. 2009. Morelloflavone, a biflavonoid, inhibits tumor 
angiogenesis by targeting rho GTPases and extracellular 
signal-regulated kinase signaling pathways. Cancer Research 
69(2): 518-525.
Pereañez, J.A., Patiño, A.C., Núñez, V. & Osorio, E. 2014. 
The biflavonoid morelloflavone inhibits the enzymatic and 
biological activities of a snake venom phospholipase A2. 
Chemico-Biological Interactions 220: 94-101.
Pinkaew, D.,  Hutadilok-Towatana,  N.,  Teng, B.B., 
Mahabusarakam, W. & Fujise, K. 2012. Morelloflavone, a 
biflavonoid inhibitor of migration-related kinases, ameliorates 
atherosclerosis in mice. American Journal of Physiology 
(Heart and Circulatory Physiology) 302: H451-H458.
Pinkaew, D., Cho, S.G., Hui, D.Y., Wiktorowicz, J.E., Hutadilok-
Towatana, N., Mahabusarakam, W., Tonganunt, M., 
Stafford, L.J., Phongdara, A., Liu, M. & Fujise, K. 2009. 
Morelloflavone blocks injury-induced neointimal formation 
by inhibiting vascular smooth muscle cell migration. 
Biochimica et Biophysica Acta 1790: 31-39.
Smith, H.W., Finkelstein, N., Aliminoso, L., Crawford, B. & 
Graber, M. 1945. The renal clearances of substituted hippuric 
and derivatives and other aromatic acids in dogs and man. 
Journal of Clinical Investigation 24: 388-404.
Tuansulong, K.A., Hutadilok-Towatana, N., Mahabusarakam, 
W., Pinkaew, D. & Fujise, K. 2011. Morelloflavone from 
Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA 
reductase. Phytotherapy Research 25: 424-428.
Verbeek, R., Plomp, A.C., van Tol, E.A. & van Noort, J.M. 2004. 
The flavones luteolin and apigenin inhibit in vitro antigen-
specific proliferation and interferon-gamma production 
by murine and human autoimmune T cells. Biochemical 
Pharmacology 68: 621-629.
Wuttidhammavej, W. 1997. Thai Traditional Medicine, 2nd ed. 
Odean Store: Bangkok.
Department of Physiology
Faculty of Science
Prince of Songkla University 
Hat Yai, Songkhla, 90112 
Thailand
*Corresponding author; email: siriphun.h@psu.ac.th
Received:  31 August 2016
Accepted:  10 April 2017
